Companies / United Kingdom
AstraZeneca Outsourcing Manufacturing
September 2007 | Industry NewsAnglo-Swedish drugmaker AstraZeneca is aiming to outsource all of its manufacturing operations within the next ten years as it looks to cut costs. Contract manufacturing organisations in Asia are expected to take on much of the burden although the transformation will not occur for many years due to complex regulatory hurdles.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
